Does the calculator show real prices?

The calculator uses provider data and starting advertised prices where available. Your final cost may vary based on medication, dose, insurance, labs, shipping, state availability, and clinician review.

What does "From $X/mo" mean?

It means the lowest publicly advertised starting monthly price we found for that provider or plan at the time of review.

Does insurance change the result?

Yes. Insurance may affect visit costs, medication coverage, prior authorization, and out-of-pocket price.

What is the difference between compounded and brand-name GLP-1 medication?

Brand-name medications are FDA-approved finished products for specific indications. Compounded GLP-1 medications are not FDA-approved finished products and may differ in formulation, labeling, dosing, and oversight.

Find the Most Affordable GLP-1 Program for Your State

Compare real provider starting prices, medication pathways, and state availability before you choose a GLP-1 telehealth program.

Start the Calculator

Tracks 15+ GLP-1 telehealth providers
Uses “From $X/mo” floor pricing from provider data
Separates compounded and brand-name pathways
Flags when medication may be separate
Includes priceLastVerified timestamps where available

GLP-1 Monthly Cost Calculator

Four questions. Each provider's real published starting price, no invented math.

1. Which medication?SemaglutideTirzepatide

2. Compounded or brand-name?Compounded

Usually 30–60% cheaper. Made by 503A/503B pharmacies.

Brand-name

Wegovy / Ozempic / Zepbound / Mounjaro. FDA-approved, often required by insurance.

3. Do you have insurance you want to use?Yes

Brand-name has the best chance of being covered.

No / paying out of pocket

Compounded is usually significantly cheaper.

4. Your state

Answer all four questions to see provider starting prices.

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Calculator results rank providers by their verified public prices, independent of payouts. See our affiliate disclosure.

How It Works

Enter your state.
Choose whether you have insurance.
Select your preferred medication pathway.
Compare providers by starting price, support model, and what to verify.

Important Disclaimer

RangeYourself provides consumer research, not medical advice. GLP-1 medications require evaluation by a licensed clinician. Compounded GLP-1 medications are not FDA-approved finished products and should not be treated as identical to brand-name medications.